Structural highlights 
| 4g5g is a 2 chain structure with sequence from Escherichia coli k-12. Full crystallographic information is available from OCA. For a guided tour on the structure components use FirstGlance. 
 | 
| Ligands: | , , | 
| NonStd Res: | , , , , , | 
| Gene: | tufA, b3339, JW3301 (Escherichia coli K-12) | 
| Resources: | FirstGlance, OCA, RCSB, PDBsum | 
  Publication Abstract from PubMed 
Synthetic studies of the antimicrobial secondary metabolite thiomuracin A (1) were initiated to improve chemical stability and physicochemical properties. Functional group modifications of 1 included removing the C2-C7 side chain, derivatizing the C84 epoxide region, and altering the C44 hydroxyphenylalanine motif. The resulting derivatives simplified and stabilized the chemical structure and were evaluated for antibacterial activity relative to 1. The simplified structure and improved organic solubility of the derivatives facilitated isolation yields from fermentation broths and simplified the procedures involved for the process. These advancements increased material supply for continued medicinal chemistry optimization and culminated in the identification of 2, a structurally simplified and chemically stable analogue of 1 which retained potent antibiotic activity.
Antibiotic optimization and chemical structure stabilization of thiomuracin A.,LaMarche MJ, Leeds JA, Dzink-Fox J, Gangl E, Krastel P, Neckermann G, Palestrant D, Patane MA, Rann EM, Tiamfook S, Yu D J Med Chem. 2012 Aug 9;55(15):6934-41. doi: 10.1021/jm300783c. Epub 2012 Jul 31. PMID:22812377[1]
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
 
 See Also
  References 
- ↑ LaMarche MJ, Leeds JA, Dzink-Fox J, Gangl E, Krastel P, Neckermann G, Palestrant D, Patane MA, Rann EM, Tiamfook S, Yu D. Antibiotic optimization and chemical structure stabilization of thiomuracin A. J Med Chem. 2012 Aug 9;55(15):6934-41. doi: 10.1021/jm300783c. Epub 2012 Jul 31. PMID:22812377 doi:http://dx.doi.org/10.1021/jm300783c